Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10947345 | 0.82 | DGAT1 (0.38) | DGAT1 | |
| SCHEMBL8346130 | 0.78 | DGAT1 (0.35) | DGAT1 | |
| SCHEMBL992 | 0.77 | DGAT1 (0.41) | DGAT1 | |
| SCHEMBL9697626 | 0.75 | DGAT1 (0.39) | DGAT1 | |
| SCHEMBL9066294 | 0.70 | DGAT1 (0.39) | DGAT1 | |
| Phosphoric Acid SCHEMBL28716950 | 0.69 | DGAT1 (0.42) | DGAT1 | |
| Phosphoric Acid SCHEMBL29828181 | 0.69 | DGAT1 (0.42) | DGAT1 | |
| SCHEMBL3178598 | 0.65 | L3MBTL1 (0.35) | DGAT1 | |
| SCHEMBL5164127 | 0.65 | DGAT1 (0.39) | DGAT1 | |
| SCHEMBL7019538 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1483253-A4 | AN ANTIMICROBIAL AGENT | UNIV GRIFFITH (AU) | 2007-03-21 | — | — | EP | disclosed |
| CN-1871247-A | Novel sulfenamides | UNIV GRIFFITH (AU) | 2006-11-29 | — | — | CN | disclosed |
| EP-1664072-A1 | NOVEL SULFENAMIDES | GRIFFITH UNIVERSITY (AU) | 2006-06-07 | — | — | EP | disclosed |
| WO-2006037185-A1 | NOVEL SULFENAMIDES AND SULFENAMIDE OXIDES | GRIFFITH UNIVERSITY (AU) | 2006-04-13 | — | — | WO | disclosed |
| US-20050124559-A1 | Antimicrobial agent | UNIVERSITY, MONASH (AU) | 2005-06-09 | — | — | US | disclosed |
| WO-2005019237-A1 | NOVEL SULFENAMIDES | GRIFFITH UNIVERSITY (AU) | 2005-03-03 | — | — | WO | disclosed |
| EP-1483253-A1 | AN ANTIMICROBIAL AGENT | GRIFFITH UNIVERSITY (AU) | 2004-12-08 | — | — | EP | disclosed |
| WO-2003070715-A1 | AN ANTIMICROBIAL AGENT | GRIFFITH UNIVERSITY (AU) | 2003-08-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050124559-A1 | Antimicrobial agent | OXSR1, OSBPL3, SIGMAR1 | DGAT1 2203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.